Affini-T Therapeutics, a biotech with roots at Fred Hutch, raises $175M for cancer treatments
March 22, 2022 at 17:50 PM EDT
The company, which has research labs in Seattle, is focusing on cell therapies for solid tumor cancers.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|